These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 10505988)
1. Current perspectives in immunotherapy. Lillehei KO; Liu Y; Kong Q Ann Thorac Surg; 1999 Sep; 68(3 Suppl):S28-33. PubMed ID: 10505988 [TBL] [Abstract][Full Text] [Related]
2. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer? Zöller M; Matzku S Arch Immunol Ther Exp (Warsz); 2002; 50(3):197-224. PubMed ID: 12098935 [TBL] [Abstract][Full Text] [Related]
3. Improving cancer immunotherapy by targeting tumor-induced immune suppression. Stewart TJ; Smyth MJ Cancer Metastasis Rev; 2011 Mar; 30(1):125-40. PubMed ID: 21249424 [TBL] [Abstract][Full Text] [Related]
4. The use of cytokines and chemokines in the cancer immunotherapy. Amedei A; Prisco D; D' Elios MM Recent Pat Anticancer Drug Discov; 2013 May; 8(2):126-42. PubMed ID: 22894642 [TBL] [Abstract][Full Text] [Related]
6. [History of Immuno-therapy - from Coley Toxins to Check-points of the Immune Reaction]. Říhová B; Šťastný M Klin Onkol; 2015; 28 Suppl 4():4S8-14. PubMed ID: 26647883 [TBL] [Abstract][Full Text] [Related]
7. Innovative cancer treatments that augment radiotherapy or chemo-therapy by the use of immunotherapy or gene therapy. Lucas R; Keisari Y Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):201-8. PubMed ID: 18221037 [TBL] [Abstract][Full Text] [Related]
11. Tracking cellular and immune therapies in cancer. Kurtz DM; Gambhir SS Adv Cancer Res; 2014; 124():257-96. PubMed ID: 25287692 [TBL] [Abstract][Full Text] [Related]
12. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
13. Cancer immunotherapy: hopes and pitfalls: a review. Ben-Efraim S Anticancer Res; 1996; 16(5B):3235-40. PubMed ID: 8920797 [TBL] [Abstract][Full Text] [Related]
14. Nanoparticles for tumor immunotherapy. Zang X; Zhao X; Hu H; Qiao M; Deng Y; Chen D Eur J Pharm Biopharm; 2017 Jun; 115():243-256. PubMed ID: 28323111 [TBL] [Abstract][Full Text] [Related]
15. Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Hernández-Luna MA; Luria-Pérez R J Immunol Res; 2018; 2018():2984247. PubMed ID: 30302344 [TBL] [Abstract][Full Text] [Related]
16. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy. Baxevanis CN; Perez SA; Papamichail M Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409 [TBL] [Abstract][Full Text] [Related]
17. Cancer vaccines. Espinoza-Delgado I Oncologist; 2002; 7 Suppl 3():20-33. PubMed ID: 12165652 [TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology? Fry TJ; Lankester AC Pediatr Clin North Am; 2008 Feb; 55(1):147-67, xi. PubMed ID: 18242319 [TBL] [Abstract][Full Text] [Related]
19. Cancer immunotherapy. Schuster M; Nechansky A; Kircheis R Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244 [TBL] [Abstract][Full Text] [Related]
20. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology? Fry TJ; Lankester AC Hematol Oncol Clin North Am; 2010 Feb; 24(1):109-27. PubMed ID: 20113898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]